Skip to content
Congress·Passed House·3 months ago

House Passes Mikaela Naylon Give Kids a Chance Act to Boost Pediatric Cancer Research

Also known as: Mikaela Naylon Give Kids a Chance Act

Legislative Progress

✓ Filed
✓ Review
✓ House
Senate
President

Impact Analysis

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Key Points

  • Drug companies will be required to study how new cancer treatments work for children, especially when used in combination with existing medicines. This aims to find better treatments for childhood cancers that are often overlooked by researchers focusing on adults.
  • The bill extends a program until 2029 that rewards companies for developing drugs for rare childhood diseases. These rewards, known as vouchers, allow companies to get a future drug reviewed faster by the government, which encourages them to invest in medicines for small groups of sick children.
  • It changes rules for 'orphan drugs' to prevent companies from having a total monopoly on a rare disease. Special protections will now only apply to the specific use of the drug that was approved, rather than the entire disease, making it easier for other companies to develop different treatments.
  • The national organ transplant system will get a technology upgrade to help more patients. This includes better electronic record sharing between hospitals and a new public dashboard to track how many transplants are happening and how many organs are unfortunately going unused.
  • Generic drug makers will get more help from the government to make sure their products match brand-name drugs exactly. By providing more transparency about ingredients, the government hopes to help cheaper generic medicines reach the market faster.
  • The bill increases funding for a Medicare improvement fund by over $1.2 billion and creates a new international office to help partner countries in the Middle East meet safety standards for medical products.
Healthcare

Milestones

3 milestones13 actions
Dec 2, 2025Senate

Received in the Senate.

Dec 1, 2025House

Motion to reconsider laid on the table Agreed to without objection.

Dec 1, 2025House

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4929-4932)

Dec 1, 2025

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4929-4932)

Dec 1, 2025House

DEBATE - The House proceeded with forty minutes of debate on H.R. 1262.

What Happens Next

Projected impacts based on AI analysis

180 days after enactment

New enforcement rules for pediatric study requirements take effect

Drug companies that fail to complete required studies on how their medicines work in children can now face penalties, pushing them to prioritize pediatric research.

3 years after enactment

New pediatric cancer investigation requirements begin applying to drug applications

Drug companies submitting new cancer drug applications will be required to also study how their treatments work in children, including combination therapies, potentially leading to more treatment options for kids with cancer.

Related News

2 articles
BioSpace·27 days ago

Rare Pediatric Disease Vouchers Reauthorized, PBM Reform Funded in Narrowly Passed Spending Bill

The signing of the Mikaela Naylon Give Kids a Chance Act ends a year of uncertainty for rare disease drug developers. The law reauthorizes the FDA's rare pediatric disease priority review voucher (PRV) program through 2029, providing financial incentives for companies to develop pediatric therapies.

C=
Washington Times·6 days ago

Americans fighting rare diseases deserve effective solutions

The Give Kids a Chance Act, recently signed into law, codifies orphan drug exclusivity based on specific FDA-approved indications rather than broad disease categories. This reform ensures companies continue developing targeted therapies for small patient populations while preventing monopolies.

R+

Source Information

Document Type

Congressional Bill

Official Title

Mikaela Naylon Give Kids a Chance Act

Bill NumberHR 1262
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReceived in the Senate.

Sponsor

Cosponsors

(250)
D: 141R: 109

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.